122 related articles for article (PubMed ID: 3330064)
1. [Drug-induced vital disorders].
Erdmann E
Internist (Berl); 1987 Feb; 28(2):116-22. PubMed ID: 3330064
[No Abstract] [Full Text] [Related]
2. [Drug therapy in advanced age].
Scholz H
Med Monatsschr Pharm; 1996 May; 19(5):132-9. PubMed ID: 8684309
[No Abstract] [Full Text] [Related]
3. [Chronobiology and chronopharmacology of cardiovascular diseases].
Lemmer B
Wien Med Wochenschr; 1995; 145(17-18):445-7. PubMed ID: 8588361
[TBL] [Abstract][Full Text] [Related]
4. Adverse drug reactions in patients with cardiovascular disease. Foreword.
Rahimtoola SH
Curr Probl Cardiol; 2008 Dec; 33(12):701. PubMed ID: 19000585
[No Abstract] [Full Text] [Related]
5. Problems and pitfalls in cardiac drug therapy.
Stone SM; Rai N; Nei J
Rev Cardiovasc Med; 2001; 2(3):126-42. PubMed ID: 12439377
[TBL] [Abstract][Full Text] [Related]
6. [Drug therapy of cardiovascular diseases in the elderly].
Kuprash LP
Med Sestra; 1983 Jan; 42(1):23-6. PubMed ID: 6550159
[No Abstract] [Full Text] [Related]
7. Cardiovascular medications.
Williams S; Wynn G; Cozza K; Sandson NB
Psychosomatics; 2007; 48(6):537-47. PubMed ID: 18071104
[No Abstract] [Full Text] [Related]
8. [The efficacy and safety of the drug treatment of cardiovascular diseases].
Mazur NA
Ter Arkh; 1993; 65(8):4-7. PubMed ID: 8211800
[No Abstract] [Full Text] [Related]
9. Tricyclic anti-depressants and the heart.
Padmakumar P; Sathyamurthy I; Sukumar IP
J Assoc Physicians India; 1983 Sep; 31(9):593-6. PubMed ID: 6365888
[No Abstract] [Full Text] [Related]
10. [Ophthalmological manifestations of the side effects of cardiovascular drugs].
Mozherenkov VP; Kalashev II
Vestn Oftalmol; 1987; 103(6):58-60. PubMed ID: 3328385
[No Abstract] [Full Text] [Related]
11. Adverse dermatologic effects of cardiovascular drug therapy.
Brosnan BD; Frishman WH; Sun DK; Grossman M
Heart Dis; 2000; 2(3):220-47. PubMed ID: 11728264
[TBL] [Abstract][Full Text] [Related]
12. [Sympathomimetics in ADHD. Cardiovascular risks, FDA warns].
Ostman-Smith I; Dellborg M
Lakartidningen; 2007 Apr 25-May 1; 104(17):1307. PubMed ID: 17547274
[No Abstract] [Full Text] [Related]
13. Avoiding psychotropic drug interactions in the cardiovascular patient.
DeVane CL; Markowitz JS
Bull Menninger Clin; 2000; 64(1):49-59. PubMed ID: 10695159
[TBL] [Abstract][Full Text] [Related]
14. Cardiovascular drugs and cancer: of competing risk, smallpox, Bernoulli, and d'Alembert.
Messerli FH; Bangalore S; Torp-Pedersen C; Staessen JA; Kostis JB
Eur Heart J; 2013 Apr; 34(15):1095-8. PubMed ID: 22815329
[No Abstract] [Full Text] [Related]
15. Adverse drug reactions in patients with cardiovascular disease.
Faulx MD; Francis GS
Curr Probl Cardiol; 2008 Dec; 33(12):703-68. PubMed ID: 19000586
[TBL] [Abstract][Full Text] [Related]
16. Doses of cardiovascular medication in elderly patients with renal impairment.
Carter BL
Coron Artery Dis; 1997; 8(8-9):495-8. PubMed ID: 9431476
[No Abstract] [Full Text] [Related]
17. Impact of medical interventions on quality of life in cardiovascular disease: a consensus viewpoint.
Arnold JM; Sasson Z; Mathias S; Black WR; Gill JB; Higginson L; Huckell V; Klinke P; MacDonald R; Morgan C; Smith E; Tasch RF; Warnica W
Can J Cardiol; 1997 Mar; 13(3):235-6. PubMed ID: 9117910
[No Abstract] [Full Text] [Related]
18. Reviewing common cardiovascular drugs.
Nursing; 2002 Mar; 32(3):56-7. PubMed ID: 11902048
[No Abstract] [Full Text] [Related]
19. Therapeutic implications of the gender-specific aspects of cardiovascular disease.
Regitz-Zagrosek V
Nat Rev Drug Discov; 2006 May; 5(5):425-38. PubMed ID: 16672926
[TBL] [Abstract][Full Text] [Related]
20. Antioxidant vitamins: getting to the heart of the matter.
Scott RS
N Z Med J; 1996 Aug; 109(1028):324. PubMed ID: 8816728
[No Abstract] [Full Text] [Related]
[Next] [New Search]
